Title

Atypical antipsychotic medications in the management of disruptive behaviors in children: Safety guidelines and recommendations

Authors

Authors

C. McKinney;K. Renk

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Clin. Psychol. Rev.

Keywords

Atypical antipsychotic medication; Children; Adolescent; Disruptive; behavior; NEUROLEPTIC MALIGNANT SYNDROME; OPEN-LABEL; LONG-TERM; 2ND-GENERATION; ANTIPSYCHOTICS; SUBAVERAGE INTELLIGENCE; RISPERIDONE TREATMENT; AUTISTIC; DISORDER; CONDUCT PROBLEMS; ADOLESCENTS; DISCONTINUATION; Psychology, Clinical

Abstract

Use of atypical antipsychotic medications (AAMs) in the treatment of Disruptive Behavior (DB) in children and adolescents has increased dramatically worldwide. However, with exception of using risperidone (i.e., for the management of irritability associated with Autism, manic and mixed episodes associated with Bipolar I Disorder, and Schizophrenia) and aripiprazole (i.e., for manic and mixed episodes associated with Bipolar I Disorder and Schizophrenia), the Food and Drug Administration (FDA) has not approved the use of AAMs in children and adolescents. Although research on use of these medications in children and adolescents has increased, mechanisms of action and long-term outcomes remain poorly understood or unknown. Particularly concerning is that use of these medications in children and adolescents may impact cognitive, social, and physical development, as side effects may interfere with activities in their educational setting, peer networks, and recreational settings. Overall, AAMs frequently are prescribed off label, control DB through sedation rather than targeting actual causes of DB, and lead to many negative side effects with unknown long-term effects. Reconsidering the use of AAMs in managing DB is encouraged strongly. (C) 2010 Elsevier Ltd. All rights reserved.

Journal Title

Clinical Psychology Review

Volume

31

Issue/Number

3

Publication Date

1-1-2011

Document Type

Review

Language

English

First Page

465

Last Page

471

WOS Identifier

WOS:000288587400015

ISSN

0272-7358

Share

COinS